Loading market dashboard
Xeris Biopharma Holdings, Inc.
XERSHealthcareNASDAQUS
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Xeris Biopharma Holdings, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $704.45M | $686.46M - $721.81M | -$253.44M | $1.12 | 3 |
| Dec 2029 | $623.67M | $607.74M - $639.04M | -$224.38M | $0.943 | 5 |
| Dec 2028 | $542.67M | $542.67M - $542.67M | -$195.24M | $0.588 | 6 |
| Dec 2027 | $473.55M | $457.11M - $489.02M | -$170.37M | $0.368 | 5 |
| Dec 2026 | $385.85M | $383.16M - $388.68M | -$138.82M | $0.145 | 5 |
| Dec 2025 | $288.22M | $285.77M - $289.38M | -$103.70M | -$0.022 | 2 |
| Dec 2024 | $201.08M | $199.30M - $203.97M | -$72.34M | -$0.359 | 5 |
| Dec 2023 | $181.41M | $176.78M - $185.88M | -$65.27M | -$0.422 | 2 |
| Dec 2022 | $107.94M | $100.81M - $120.99M | -$61.36M | -$0.674 | 1 |
| Dec 2021 | $47.47M | $44.33M - $53.21M | -$26.99M | -$1.218 | 1 |
| Dec 2020 | $22.03M | $20.58M - $24.70M | -$12.52M | -$2.14 | 2 |
| Dec 2019 | $1.50M | $1.40M - $1.68M | -$853.4K | -$4.714 | 1 |